DNA And Gene Cloning Services Global Market Report 2025

The DNA and gene cloning services market size has grown rapidly in recent years. It will grow from $2.69 billion in 2024 to $3.07 billion in 2025 at a compound annual growth rate (CAGR) of 14.2%. The growth during the historic period can be attributed to the increasing demand for personalized medicine, rising investments in biopharmaceutical research, a growing prevalence of genetic disorders, expanding applications in agriculture and biotechnology, and supportive government funding for genomic studies.

The DNA and gene cloning services market size is expected to see rapid growth in the next few years. It will grow to $5.16 billion in 2029 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to the increasing demand for personalized medicine, rising applications in gene therapy, growing investments in biopharmaceutical R&D, expanding use of synthetic biology, supportive government regulations and funding for biotechnology, and the growing prevalence of genetic disorders. Key trends expected during this period include enhanced CRISPR-Cas9 precision, cost-effective next-generation sequencing, automated cloning platforms, high-throughput screening methods, synthetic biology innovations, AI-driven gene analysis, and improved vector design for therapeutic applications.

The growing adoption of gene therapy is expected to drive the expansion of the DNA and gene cloning services market. Gene therapy is a treatment approach that involves modifying a person's genes to treat or prevent diseases. This can include replacing defective genes, deactivating harmful ones, or adding new genes to address illnesses. The increasing use of gene therapy is driven by its potential to treat previously incurable genetic disorders, advancements in biotechnology, and heightened awareness among healthcare professionals and patients. DNA and gene cloning services play a vital role in gene therapy by facilitating the development of targeted genetic modifications for treating genetic disorders. For example, in April 2024, the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, reported that the number of phase III gene therapy clinical trials increased by 10% in the fourth quarter, marking the first rise since the third quarter of 2022. Thus, the rise in gene therapy is propelling the growth of the DNA and gene cloning services market.

Companies in the DNA and gene cloning services market are focusing on technological advancements, including artificial intelligence (AI)-generated gene editors, to improve accuracy, reduce development time, and streamline processes for customized genetic modifications and therapeutic applications. An AI-generated gene editor is a tool or system optimized or designed with artificial intelligence to enhance gene-editing precision. For example, in April 2024, Profluent, a US-based biotechnology research company, introduced OpenCRISPR-1, an AI-designed gene editor. This innovative tool demonstrates precise genome editing using customizable CRISPR-like proteins created through large language models, greatly expanding CRISPR capabilities and transforming genetic science.

In November 2022, Myriad Genetics Inc., a US-based company specializing in genetic testing and personalized medicine, acquired Gateway Genomics for $67.5 million. This acquisition enhances Myriad's capabilities in women's health and oncology testing, offering patients more comprehensive and personalized genetic testing solutions. Gateway Genomics LLC is a US-based company focused on developing prenatal and pediatric genomic tests.

Major players in the DNA and gene cloning services market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Eurofins Scientific, Agilent Technologies Inc., Lonza Group, Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne, Curia Global Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Syngene International Limited, Twist Bioscience, New England Biolabs Inc., Origene Technologies Inc., MedGenome, Sino Biological, Genewiz Inc., Creative Biogene, and Addgene.

North America was the largest region in the DNA and gene cloning services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in DNA and gene cloning services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the DNA and gene cloning services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Deoxyribonucleic acid (DNA) and gene cloning services encompass laboratory techniques used to generate copies of specific DNA sequences or genes. These services involve inserting a gene of interest into a plasmid vector, which is then introduced into a host organism, such as bacteria, to replicate and produce multiple copies. This process is crucial for various applications in research, medicine, and biotechnology.

The primary types of genes involved in DNA and gene cloning services include standard genes, complex genes, and other variations. A standard gene is a well-defined gene with a known sequence and function, often used as a reference or control in cloning procedures. The services provided include gene synthesis, custom cloning, subcloning, and others, applied in DNA sequencing, mutagenesis, and genotyping. These services are utilized by end users across academic and research institutions, pharmaceutical and biotechnology companies, and other sectors.

The DNA and gene cloning services market research report is one of a series of new reports that provides DNA and gene cloning services market statistics, including the DNA and gene cloning services industry's global market size, regional shares, competitors with a DNA and gene cloning services market share, detailed DNA and gene cloning services market segments, market trends and opportunities, and any further data you may need to thrive in the DNA and gene cloning services industry. This DNA and gene cloning services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The DNA and gene cloning services market includes revenues earned by entities by providing services such as vector design and cloning, library construction, quality control and validation, plasmid preparation, and mutagenesis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.